Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term intensive insulin therapy in newly diagnosed type 2 diabetes
NCT03030300Phase 4Completed
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Jan 2008
- Primary completion
- Feb 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Novolin 70/30 in type 2 diabetes mellitus (T2DM), sponsored by Shandong Provincial Qianfoshan Hospital. Started Jan 2008; status: completed.
02
Drugs
Novolin 70/30
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03030300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03030300.